FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022259480> ?p ?o ?g. }

• W2022259480 endingPage "489" @default.
• W2022259480 startingPage "479" @default.
• W2022259480 abstract "The present study evaluates the effects of methotrexate (MTX) and chloroquine (CQ), and of combined MTX + CQ treatment, on the inflammatory response and on plasma and liver phosphatase and transaminase activities, employing an adjuvant-induced arthritis model in rats. Arthritis was induced by the intradermal injection of a suspension of Mycobacterium tuberculosis in mineral oil into the plantar surface of the hind paws. Development of the inflammatory response was assessed over a 21-day period. Animal groups received either: (i) MTX, administered i.p., weekly, in 0.15, 1.5, 3, 6 or 12 mg/kg doses; (ii) CQ, given intragastrically, in daily 25 or 50 mg/kg doses; or (iii) MTX + CQ, administered in two combinations (MTX1.5 mg/kg + CQ50 mg/kg, or MTX6 mg/kg + CQ50 mg/kg). At the end of the experimental period, the animals were anesthetized and killed, blood and liver samples were collected and prepared for measurement of acid and alkaline phosphatase (AP, ALP), and aspartate (AST) and alanine aminotransferase (ALT) activities. MTX at 6 and 12 mg/kg reduced the inflammatory response while CQ had no effect. MTX6 mg/kg + CQ50 mg/kg reduced the inflammatory response similar to MTX12 mg/kg, without affecting the bone marrow. Plasma AP and liver ALP activities were very elevated in the arthritic rats. While MTX treatment partially reduced both plasma AP and liver ALP activities at all doses used in the arthritic rats, CQ treatment reduced plasma AP, but increased liver AP activity. MTX + CQ treatment decreased plasma AP and liver ALP activities in the arthritic rats to control values. Plasma and liver AST activities were unaltered in the arthritic rats, and were unaffected by treatment. However, plasma and liver ALT activities were significantly reduced in the arthritic rats. While MTX or CQ treatment did not alter plasma transaminase activity in the arthritic rats, after MTX + CQ treatment, plasma ALT activity returned to normal values. In conclusion, the present data suggest that MTX + CQ treatment provides more effective anti-inflammatory protection against adjuvant-induced arthritis than does MTX alone, reverting the alterations in enzyme activities induced by this inflammatory disease in rats." @default.
• W2022259480 created "2016-06-24" @default.
• W2022259480 creator A5001114036 @default.
• W2022259480 creator A5020164379 @default.
• W2022259480 creator A5025647184 @default.
• W2022259480 creator A5029726638 @default.
• W2022259480 creator A5050516725 @default.
• W2022259480 creator A5077986752 @default.
• W2022259480 creator A5081883587 @default.
• W2022259480 date "2005-06-09" @default.
• W2022259480 modified "2023-10-12" @default.
• W2022259480 title "Efficiency of combined methotrexate/chloroquine therapy in adjuvant-induced arthritis" @default.
• W2022259480 cites W1974065253 @default.
• W2022259480 cites W1978576762 @default.
• W2022259480 cites W1988848155 @default.
• W2022259480 cites W1997219133 @default.
• W2022259480 cites W2000004763 @default.
• W2022259480 cites W2025520284 @default.
• W2022259480 cites W2029252545 @default.
• W2022259480 cites W2042585107 @default.
• W2022259480 cites W2048807628 @default.
• W2022259480 cites W2055267721 @default.
• W2022259480 cites W2062841370 @default.
• W2022259480 cites W2070943458 @default.
• W2022259480 cites W2074438676 @default.
• W2022259480 cites W2091100755 @default.
• W2022259480 cites W2091566696 @default.
• W2022259480 cites W2092353997 @default.
• W2022259480 cites W2104607610 @default.
• W2022259480 cites W2125062098 @default.
• W2022259480 cites W2126181733 @default.
• W2022259480 cites W2158392523 @default.
• W2022259480 cites W2319957449 @default.
• W2022259480 cites W2340199679 @default.
• W2022259480 cites W4241917186 @default.
• W2022259480 cites W82285130 @default.
• W2022259480 doi "https://doi.org/10.1111/j.1472-8206.2005.00346.x" @default.
• W2022259480 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16011736" @default.
• W2022259480 hasPublicationYear "2005" @default.
• W2022259480 type Work @default.
• W2022259480 sameAs 2022259480 @default.
• W2022259480 citedByCount "14" @default.
• W2022259480 countsByYear W20222594802013 @default.
• W2022259480 countsByYear W20222594802014 @default.
• W2022259480 countsByYear W20222594802015 @default.
• W2022259480 countsByYear W20222594802016 @default.
• W2022259480 countsByYear W20222594802017 @default.
• W2022259480 countsByYear W20222594802020 @default.
• W2022259480 crossrefType "journal-article" @default.
• W2022259480 hasAuthorship W2022259480A5001114036 @default.
• W2022259480 hasAuthorship W2022259480A5020164379 @default.
• W2022259480 hasAuthorship W2022259480A5025647184 @default.
• W2022259480 hasAuthorship W2022259480A5029726638 @default.
• W2022259480 hasAuthorship W2022259480A5050516725 @default.
• W2022259480 hasAuthorship W2022259480A5077986752 @default.
• W2022259480 hasAuthorship W2022259480A5081883587 @default.
• W2022259480 hasConcept C126322002 @default.
• W2022259480 hasConcept C160160445 @default.
• W2022259480 hasConcept C181199279 @default.
• W2022259480 hasConcept C185592680 @default.
• W2022259480 hasConcept C2777077863 @default.
• W2022259480 hasConcept C2777575956 @default.
• W2022259480 hasConcept C2778606649 @default.
• W2022259480 hasConcept C2779679107 @default.
• W2022259480 hasConcept C2781059491 @default.
• W2022259480 hasConcept C55493867 @default.
• W2022259480 hasConcept C71924100 @default.
• W2022259480 hasConcept C98274493 @default.
• W2022259480 hasConceptScore W2022259480C126322002 @default.
• W2022259480 hasConceptScore W2022259480C160160445 @default.
• W2022259480 hasConceptScore W2022259480C181199279 @default.
• W2022259480 hasConceptScore W2022259480C185592680 @default.
• W2022259480 hasConceptScore W2022259480C2777077863 @default.
• W2022259480 hasConceptScore W2022259480C2777575956 @default.
• W2022259480 hasConceptScore W2022259480C2778606649 @default.
• W2022259480 hasConceptScore W2022259480C2779679107 @default.
• W2022259480 hasConceptScore W2022259480C2781059491 @default.
• W2022259480 hasConceptScore W2022259480C55493867 @default.
• W2022259480 hasConceptScore W2022259480C71924100 @default.
• W2022259480 hasConceptScore W2022259480C98274493 @default.
• W2022259480 hasIssue "4" @default.
• W2022259480 hasLocation W20222594801 @default.
• W2022259480 hasLocation W20222594802 @default.
• W2022259480 hasOpenAccess W2022259480 @default.
• W2022259480 hasPrimaryLocation W20222594801 @default.
• W2022259480 hasRelatedWork W130231721 @default.
• W2022259480 hasRelatedWork W1552579474 @default.
• W2022259480 hasRelatedWork W1970022001 @default.
• W2022259480 hasRelatedWork W1974752855 @default.
• W2022259480 hasRelatedWork W2051346378 @default.
• W2022259480 hasRelatedWork W2365450081 @default.
• W2022259480 hasRelatedWork W2368110119 @default.
• W2022259480 hasRelatedWork W2745085879 @default.
• W2022259480 hasRelatedWork W3033516131 @default.
• W2022259480 hasRelatedWork W4320926217 @default.
• W2022259480 hasVolume "19" @default.
• W2022259480 isParatext "false" @default.
• W2022259480 isRetracted "false" @default.

• next